BNKL (Bionik Laboratories) Days Payable: 173.45 (As of Mar. 2023)


BNKL Bionik Laboratories Corp BNKL
12 GF Score
Price $0.00
View Full Analysis

What is Bionik Laboratories Days Payable?

Bionik Laboratories BNKL -99.00% 12 Days Payable is 173.45 as of Mar. 2023. GuruFocus rates BNKL with a GF Score™ of 12/100.

Bionik Laboratories's average Accounts Payable for the three months ended in Mar. 2023 was $0.47 Mil. Bionik Laboratories's Cost of Goods Sold for the three months ended in Mar. 2023 was $0.25 Mil. Hence, Bionik Laboratories's Days Payable for the three months ended in Mar. 2023 was 173.45.

The historical rank and industry rank for Bionik Laboratories's Days Payable or its related term are showing as below:

BNKL's Days Payable is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 58
* Ranked among companies with meaningful Days Payable only.

Bionik Laboratories's Days Payable declined from Mar. 2022 (382.31) to Mar. 2023 (173.45). It may suggest that Bionik Laboratories accelerated paying its suppliers.

Bionik Laboratories Days Payable Historical Data

* Premium members only.

The historical data trend for Bionik Laboratories's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionik Laboratories Days Payable Chart

Bionik Laboratories Annual Data
Trend Dec14 Dec15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 209.82 409.96 890.11 432.09 193.25

Bionik Laboratories Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 382.31 445.30 189.05 110.01 173.45

BNKL vs ARPC, GRST, IONM: Days Payable Comparison

For the Medical Care Facilities subindustry, Bionik Laboratories's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bionik Laboratories Days Payable vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Bionik Laboratories's Days Payable distribution charts can be found below:

* The bar in red indicates where Bionik Laboratories's Days Payable falls into.


BNKL
12GF Score
Bionik Laboratories Corp BNKL
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bionik Laboratories Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Bionik Laboratories's Days Payable for the fiscal year that ended in Mar. 2023 is calculated as

Days Payable (A: Mar. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Mar. 2022 ) + Accounts Payable (A: Mar. 2023 )) / count ) / Cost of Goods Sold (A: Mar. 2023 )*Days in Period
=( (0.305 + 0.558) / 2 ) / 0.815*365
=0.4315 / 0.815*365
=193.25

Bionik Laboratories's Days Payable for the quarter that ended in Mar. 2023 is calculated as:

Days Payable (Q: Mar. 2023 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2022 ) + Accounts Payable (Q: Mar. 2023 )) / count ) / Cost of Goods Sold (Q: Mar. 2023 )*Days in Period
=( (0.381 + 0.558) / 2 ) / 0.247*365 / 4
=0.4695 / 0.247*365 / 4
=173.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 173.45 mean?
Bionik Laboratories (BNKL) has a Days Payable of 173.45 as of Mar. 2023. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bionik Laboratories and its competitors.
Is Bionik Laboratories' Days Payable too high?
Bionik Laboratories' current Days Payable is 173.45. The Healthcare Providers & Services industry median Days Payable is 58.00. Bionik Laboratories' value of 173.45 is 199.1% above this industry median. Overall, Bionik Laboratories has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Bionik Laboratories' Days Payable compare to ARPC and GRST?
Bionik Laboratories' Days Payable of 173.45 can be compared against companies in the Healthcare Providers & Services industry. The industry median Days Payable is 58.00. Bionik Laboratories' value of 173.45 is 199.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.00, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bionik Laboratories's current Days Payable of 173.45 is 199.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bionik Laboratories and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bionik Laboratories's current Days Payable is 173.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bionik Laboratories stock overvalued right now?
Bionik Laboratories (BNKL) has a current Days Payable of 173.45. The current Days Payable is 173.45 and 199.1% above the Healthcare Providers & Services industry median of 58.00. Bionik Laboratories' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Bionik Laboratories (BNKL), the current Days Payable is 173.45 as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bionik Laboratories Business Description

Address 80 Coolidge Hill Road, Watertown, MA, USA, 02472
Bionik Laboratories Corp is a healthcare company focused on improving the quality of life of millions of people with neurological or mobility impairments by combining artificial intelligence and robotics technology to help individuals from hospital to home regain mobility, enhance autonomy, and regain self-esteem. The company uses artificial intelligence and machine learning technologies to make rehabilitation methods and processes smarter and more intuitive to deliver a greater recovery for patients with neurological or mobility impairments. Its products The InMotion ARM, and InMotion ARM/HAND are robotic therapies for the upper limbs.
12GF Score

Get the complete analysis for BNKL

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price